Article Information
History
- February 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Joachim Mariën1,2,*,
- Johan Michiels1,
- Leo Heyndrickx1,
- Antoine Nkuba-Ndaye3,
- Ann Ceulemans1,
- Koen Bartholomeeusen1,
- Joule Madinga3,
- Placide Mbala-Kingebeni3,
- Veerle Vanlerberghe4,
- Steve Ahuka-Mundeke3,
- Lin-Fa Wang5,6 and
- Kevin K. Ariën1,7
- 1Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
- 2Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium
- 3Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo
- 4Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
- 5Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
- 6SingHealth Duke-NUS Global Health Institute, Singapore
- 7University of Antwerp, Antwerp, Belgium
- ↵*Corresponding author; email: joachim_marien{at}hotmail.com
Posted February 25, 2021.
Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
